{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:41:13Z","timestamp":1761716473673},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2009,8,19]],"date-time":"2009-08-19T00:00:00Z","timestamp":1250640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s10067-009-1256-2","type":"journal-article","created":{"date-parts":[[2009,8,18]],"date-time":"2009-08-18T03:45:24Z","timestamp":1250567124000},"page":"1359-1364","source":"Crossref","is-referenced-by-count":22,"title":["Pamidronate treatment in rheumatology practice: a comprehensive review"],"prefix":"10.1007","volume":"28","author":[{"given":"Gleb","family":"Slobodin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itzhak","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Feld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doron","family":"Rimar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Rozenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Boulman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majed","family":"Odeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,19]]},"reference":[{"key":"1256_CR1","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/art.10139","volume":"46","author":"WP Maksymowych","year":"2002","unstructured":"Maksymowych WP, Jhangri GS, Fitzgerald AA, LeClercq S, Chiu P, Yan A et al (2002) A six-months randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60\u00a0mg versus 10\u00a0mg) in the treatment of nonsteroidal anti-inflammatory drug-refractory ankylosing spondylitis. Arthritis Rheum 46:766\u2013773","journal-title":"Arthritis Rheum"},{"key":"1256_CR2","first-page":"714","volume":"25","author":"WP Maksymowych","year":"1998","unstructured":"Maksymowych WP, Jhangri GS, LeClercq S, Skeith K, Yan A, Russell AS (1998) An open study of pamidronate in the treatment of refractory ankylosing spondylitis. J Rheumatol 25:714\u2013717","journal-title":"J Rheumatol"},{"key":"1256_CR3","first-page":"144","volume":"28","author":"WP Maksymowych","year":"2001","unstructured":"Maksymowych WP, Lambert R, Jhangri GS, LeClercq S, Chiu P, Wong B et al (2001) Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy. J Rheumatol 28:144\u2013155","journal-title":"J Rheumatol"},{"key":"1256_CR4","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/rheumatology\/keg256","volume":"42","author":"H Haibel","year":"2003","unstructured":"Haibel H, Brandt J, Rudwaleit M, Soerensen H, Sieper J, Braun J (2003) Treatment of active ankylosing spondylitis with pamidronate. Rheumatology 42:1018\u20131020","journal-title":"Rheumatology"},{"key":"1256_CR5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/ard.2004.022871","volume":"64","author":"AP Cairns","year":"2005","unstructured":"Cairns AP, Wright SA, Taggart AJ, Coward SM, Wright GD (2005) An open study of pulse pamidronate treatment in severe ankylosing spondylitis, and its effect on biochemical markers of bone turnover. Ann Rheum Dis 64:338\u2013339","journal-title":"Ann Rheum Dis"},{"key":"1256_CR6","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/ard.2005.041392","volume":"65","author":"R Grover","year":"2006","unstructured":"Grover R, Shankar S, Aneja R, Marwaha V, Gupta R, Kumar A (2006) Treatment of ankylosing spondylitis with pamidronate: an open label study. Ann Rheum Dis 65:688\u2013689","journal-title":"Ann Rheum Dis"},{"key":"1256_CR7","first-page":"348","volume":"24","author":"E Toussirot","year":"2006","unstructured":"Toussirot E, Le Huede G, Lohse A, Cedos J-P, Wendling D (2006) Transient efficacy of pulse pamidronate treatment in active spondyloarthropathies: an open study of 35 cases. Clin Exp Rheumatol 24:348","journal-title":"Clin Exp Rheumatol"},{"key":"1256_CR8","first-page":"2754","volume":"28","author":"WP Maksymowych","year":"2001","unstructured":"Maksymowych WP, Aaron S, Russell AS (2001) Treatment of refractory symphysitis pubis with intravenous pamidronate. J Rheumatol 28:2754\u20132757","journal-title":"J Rheumatol"},{"key":"1256_CR9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/rheumatology\/41.2.231-a","volume":"41","author":"H Marshall","year":"2002","unstructured":"Marshall H, Bromilow J, Thomas AL, Arden NK (2002) Pamidronate: a novel treatment for the SAPHO syndrome? Rheumatology 41:231\u2013233","journal-title":"Rheumatology"},{"key":"1256_CR10","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/rheumatology\/41.10.1196","volume":"41","author":"PA Courtney","year":"2002","unstructured":"Courtney PA, Hosking DJ, Fairbairn KJ, Deighton CM (2002) Treatment of SAPHO with pamidronate. Rheumatology 41:1196\u20131198","journal-title":"Rheumatology"},{"key":"1256_CR11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1297-319X(02)00419-0","volume":"69","author":"S Guignard","year":"2002","unstructured":"Guignard S, Job-Deslandre C, Sayag-Boukris V, Kahan A (2002) Pamidronate treatment in SAPHO syndrome. Joint Bone Spine 69:392\u2013396","journal-title":"Joint Bone Spine"},{"key":"1256_CR12","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/rheumatology\/keh149","volume":"43","author":"H Amital","year":"2004","unstructured":"Amital H, Applbaum YH, Aamar S, Daniel N, Rubinow A (2004) SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology 43:658\u2013661","journal-title":"Rheumatology"},{"key":"1256_CR13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/rheumatology\/keh466","volume":"44","author":"M Valls-Roc","year":"2005","unstructured":"Valls-Roc M, Sanmarti M, Salles M, Holgado S, Olive A (2005) SAPHO syndrome and pamidronate revisited. Rheumatology 44:137","journal-title":"Rheumatology"},{"key":"1256_CR14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/0378-6323.16622","volume":"71","author":"R Tehrani","year":"2005","unstructured":"Tehrani R (2005) SAPHO syndrome treated with pamidronate. Indian J Dermatol Venereol Leprol 71:273\u2013275","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"1256_CR15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/rheumatology\/kei160","volume":"45","author":"E Solau-Gervais","year":"2006","unstructured":"Solau-Gervais E, Soubrier M, Gerot I, Grange L, Puechal X, Sordet C et al (2006) The usefulness of bone remodeling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome. Rheumatology 45:339\u2013342","journal-title":"Rheumatology"},{"key":"1256_CR16","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/rheumatology\/keh295","volume":"34","author":"C Kerrison","year":"2004","unstructured":"Kerrison C, Davidson JE, Cleary AG, Beresford MW (2004) Pamidronate in the treatment of childhood SAPHO syndrome. Rheumatology 34:1246\u20131251","journal-title":"Rheumatology"},{"key":"1256_CR17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jpeds.2007.08.047","volume":"152","author":"PJ Simm","year":"2008","unstructured":"Simm PJ, Allen RC, Zacharin MR (2008) Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis. J Pediatr 152:571\u2013575","journal-title":"J Pediatr"},{"key":"1256_CR18","first-page":"707","volume":"35","author":"H Gleeson","year":"2008","unstructured":"Gleeson H, Wiltshire E, Briody J, Hall J, Chaitow J, Sillence D et al (2008) Childhood chronic recurrent multifocal osteomyelitis: pamidronate therapy decreases pain and improves vertebral shape. J Rheumatol 35:707\u2013712","journal-title":"J Rheumatol"},{"key":"1256_CR19","first-page":"2418","volume":"27","author":"M-H Guyot-Drouot","year":"2000","unstructured":"Guyot-Drouot M-H, Solau-Gervais E, Cortet B, Deprez X, Chastanet P, Cotten A et al (2000) Rheumatologic manifestations of pachydermoperiostosis and preliminary experience with bisphosphonates. J Rheumatol 27:2418\u20132423","journal-title":"J Rheumatol"},{"key":"1256_CR20","first-page":"340","volume":"54","author":"A Bhansali","year":"2006","unstructured":"Bhansali A, Singh R, Sriraam M, Bhadada S (2006) Pachydermoperiostitis and bisphosphonates. J Assoc Physicians India 54:340","journal-title":"J Assoc Physicians India"},{"key":"1256_CR21","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1378\/chest.121.4.1363","volume":"121","author":"LA Garske","year":"2002","unstructured":"Garske LA, Bell SC (2002) Pamidronate results in symptom control of hypertrophic pulmonary osteoarthropathy in cystic fibrosis. Chest 121:1363\u20131364","journal-title":"Chest"},{"key":"1256_CR22","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s10067-004-0941-4","volume":"23","author":"H Amital","year":"2004","unstructured":"Amital H, Applbaum YH, Vasiliev L, Rubinow A (2004) Hypertrophic pulmonary osteoarthropathy: control of pain and symptoms with pamidronate. Clin Rheumatol 23:330\u2013332","journal-title":"Clin Rheumatol"},{"key":"1256_CR23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1445-5994.1997.tb01983.x","volume":"27","author":"D Speden","year":"1997","unstructured":"Speden D, Nicklason F, Francis H, Ward J (1997) The use of pamidronate in hypertrophic pulmonary osteoarthropathy. Aust N Z Med 27:307\u2013310","journal-title":"Aust N Z Med"},{"key":"1256_CR24","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/00001813-200110000-00004","volume":"12","author":"T Suzuma","year":"2001","unstructured":"Suzuma T, Sakurai T, Yoshimura G, Umemura T, Tamaki T, Yoshimasu T et al (2001) Pamidronate-induced remission of pain associated with hypertrophic pulmonary osteoarthropathy in chemoendocrine therapy-refractory inoperable metastatic breast carcinoma. Anticancer Drugs 12:731\u2013734","journal-title":"Anticancer Drugs"},{"key":"1256_CR25","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/rheumatology\/39.5.567","volume":"39","author":"AJ Abdulla","year":"2000","unstructured":"Abdulla AJ (2000) Use of pamidronate for acute pain relief following osteoporotic vertebral fractures. Rheumatology 39:567\u2013568","journal-title":"Rheumatology"},{"key":"1256_CR26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s100670050099","volume":"18","author":"V Gangji","year":"1999","unstructured":"Gangji V, Appelboom T (1999) Analgesic effect of intravenous pamidronate on chronic back pain due to osteoporotic vertebral fractures. Clin Rheum 18:266\u2013267","journal-title":"Clin Rheum"},{"key":"1256_CR27","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00198-006-0169-z","volume":"17","author":"T Armingeat","year":"2006","unstructured":"Armingeat T, Brondino R, Pham T, Legre V, Lafforgue P (2006) Intravenous pamidronate for pain relief in recent osteoporotic vertebral compression fracture: a randomized double-blind controlled study. Osteoporos Int 17:1659\u20131665","journal-title":"Osteoporos Int"},{"key":"1256_CR28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10067-005-0159-0","volume":"25","author":"M Laroche","year":"2006","unstructured":"Laroche M, Cantogrel S, Jamard B, Constantin A, Zabranieski L, Cantagrel A et al (2006) Comparison of the analgesic efficacy of pamidronate and synthetic human calcitonin in osteoporotic vertebral fractures: a double-blind controlled study. Clin Rheumatol 25:683\u2013686","journal-title":"Clin Rheumatol"},{"key":"1256_CR29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jbspin.2007.04.007","volume":"74","author":"D Poujol","year":"2007","unstructured":"Poujol D, Ristori JM, Dubost JJ, Soubrier M (2007) Efficacy of pamidronate in erosive degenerative disk disease: a pilot study. Joint Bone Spine 74:663\u2013664","journal-title":"Joint Bone Spine"},{"issue":"6","key":"1256_CR30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10067-009-1112-4","volume":"28","author":"J Feld","year":"2009","unstructured":"Feld J, Rosner I, Avshovich N, Boulman N, Slobodin G, Rozenbaum M (2009) An open study of pamidronate in the treatment of refractory degenerative lumbar spinal stenosis. Clin Rheum 28(6):715\u2013717","journal-title":"Clin Rheum"},{"key":"1256_CR31","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0885-3924(03)00201-X","volume":"26","author":"M Pappagallo","year":"2003","unstructured":"Pappagallo M, Breuer B, Schneider A, Sperber K (2003) Treatment of chronic mechanical spinal pain with intravenous pamidronate: a review of medical records. J Pain Symptom Manage 26:678\u2013683","journal-title":"J Pain Symptom Manage"},{"key":"1256_CR32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1464-5491.1994.tb00225.x","volume":"11","author":"PL Selby","year":"1994","unstructured":"Selby PL, Young MJ, Boulton AJ (1994) Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med 11:28\u201331","journal-title":"Diabet Med"},{"key":"1256_CR33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MAJ.0b013e3180a5e957","volume":"335","author":"A Naqvi","year":"2008","unstructured":"Naqvi A, Cuchacovich R, Saketkoo L, Espinosa LR (2008) Acute Charcot arthropathy successfully treated with pamidronate: long-term follow-up. Am J Med Sci 335:145\u2013148","journal-title":"Am J Med Sci"},{"key":"1256_CR34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/j.jfas.2004.07.005","volume":"43","author":"JJ Anderson","year":"2004","unstructured":"Anderson JJ, Woelffer KE, Holtzman JJ, Jacobs AM (2004) Bisphosphonates for the treatment of Charcot neuroarthropathy. J Foot Ankle Surgery 43:285\u2013289","journal-title":"J Foot Ankle Surgery"},{"key":"1256_CR35","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1007\/s001250100008","volume":"44","author":"EB Jude","year":"2001","unstructured":"Jude EB, Selby PL, Burgess J, Lilleystone P, Mawer EB, Page SR et al (2001) Bisphosphonates in the treatment og Charcot neuroarthropathy: a double-blind randomized control trial. Diabetologia 44:2032\u20132037","journal-title":"Diabetologia"},{"issue":"Suppl","key":"1256_CR36","first-page":"S122","volume":"3","author":"JP Devogelaer","year":"1988","unstructured":"Devogelaer JP, Dall'Armellina S, Huaux JP, Nagant de Deuxchaines C (1988) Dramatic improvement of intractable reflex sympathetic dystrophy syndrome by intravenous infusions of the second generation bisphosphonate APD [abstract]. J Bone Min Res 3(Suppl):S122","journal-title":"J Bone Min Res"},{"key":"1256_CR37","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/01.ajp.0000146167.23153.b0","volume":"21","author":"SC Brown","year":"2005","unstructured":"Brown SC, Jeavons M, Stinson J (2005) Effectiveness of pamidronate for treating intractable chronic neuropathic pain. Case report of two adolescents. Clin J Pain 21:549\u2013552","journal-title":"Clin J Pain"},{"key":"1256_CR38","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/ard.54.8.687-a","volume":"54","author":"JF Maillefert","year":"1995","unstructured":"Maillefert JF, Chatard C, Owen S, Peere T, Tavernier C, Tebib J (1995) Treatment of refractory reflex sympathetic dystrophy with pamidronate. Ann Rheum Dis 54:687","journal-title":"Ann Rheum Dis"},{"key":"1256_CR39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF02238763","volume":"16","author":"B Cortet","year":"1997","unstructured":"Cortet B, Flipo R-M, Coquerelle P, Duquesnoy B, Delcambre B (1997) Treatment of severe, recalcitrant reflex sympathetic dystrophy: assessment of efficacy and safety of the second generation bisphosphonate pamidronate. Clin Rheum 16:51\u201356","journal-title":"Clin Rheum"},{"key":"1256_CR40","first-page":"8","volume":"26","author":"JF Maillefert","year":"1999","unstructured":"Maillefert JF, Cortet B, Aho S (1999) Pooled results from 2 trials evaluating bisphosphonates in reflex sympathetic dystrophy. J Rheumatol 26:8","journal-title":"J Rheumatol"},{"key":"1256_CR41","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/rheumatology\/40.12.1394","volume":"40","author":"I Kubalek","year":"2001","unstructured":"Kubalek I, Fain O, Paries J, Kettaneh A, Thomas M (2001) Treatment of reflex sympathetic dystrophy with pamidronate: 29 cases. Rheumatology 40:1394\u20131397","journal-title":"Rheumatology"},{"key":"1256_CR42","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1526-4637.2004.04038.x","volume":"5","author":"JN Robinson","year":"2004","unstructured":"Robinson JN, Sandom J, Chapman PT (2004) Efficacy of pamidronate in complex regional pain syndrome type I. Pain Med 5:276\u2013280","journal-title":"Pain Med"},{"key":"1256_CR43","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S8756-3282(02)00812-8","volume":"31","author":"M Varenna","year":"2002","unstructured":"Varenna M, Zucchi F, Binelli L, Failoni S, Gallazzi M, Sinigaglia L (2002) Intravenous pamidronate in the treatment of transient osteoporosis of the hip. Bone 31:96\u2013101","journal-title":"Bone"},{"key":"1256_CR44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0885-3924(02)00478-5","volume":"24","author":"EB Petcu","year":"2002","unstructured":"Petcu EB, Schug SA, Smith RH (2002) Clinical evaluation of onset of analgesia using intravenous pamidronate in metastatic bone pain. J Pain Symptom Manage 24:281\u2013282","journal-title":"J Pain Symptom Manage"},{"key":"1256_CR45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3959(98)00135-3","volume":"78","author":"F Fulfaro","year":"1998","unstructured":"Fulfaro F, Cassucio A, Ticozzi C, Ripamonti C (1998) The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials. Pain 78:157\u2013169","journal-title":"Pain"},{"key":"1256_CR46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0304-3959(00)00447-4","volume":"91","author":"A Bonabello","year":"2001","unstructured":"Bonabello A, Galmozzi MR, Bruzzese T, Zara GP (2001) Analgesic effect of biphosphonates in mice. Pain 91:269\u2013275","journal-title":"Pain"},{"key":"1256_CR47","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S8756-3282(03)00229-1","volume":"33","author":"A Bonabello","year":"2003","unstructured":"Bonabello A, Galmozzi MR, Canaparo R, Serpe L, Zara GP (2003) Long-term analgesic effect of clodronate in rodents. Bone 33:567\u2013574","journal-title":"Bone"},{"key":"1256_CR48","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/jbmr.5650051005","volume":"5","author":"MG Ceccini","year":"1990","unstructured":"Ceccini MG, Fleisch H (1990) Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouth mononuclear phagocyte lineage. J Bone Miner Res 5:1019\u20131027","journal-title":"J Bone Miner Res"},{"key":"1256_CR49","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1023\/A:1016281608773","volume":"12","author":"N Pennanen","year":"1995","unstructured":"Pennanen N, Lapinjoki S, Urtti S, Monkkonen J (1995) Effect of liposomal and free biphosphonates on the IL-1\u03b2, IL-6 and TNF\u03b1 secretion from RAW 264 cells in vitro. Pharmacol Res 12:916\u2013922","journal-title":"Pharmacol Res"},{"key":"1256_CR50","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s002239900353","volume":"61","author":"D Thiebaud","year":"1997","unstructured":"Thiebaud D, Sauty A, Burckhardt P, Leuenberger P, Sitzler L, Green JR et al (1997) An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates. Calcif Tissue Int 61:386\u2013392","journal-title":"Calcif Tissue Int"},{"key":"1256_CR51","first-page":"13","volume":"19","author":"JF Offel Van","year":"2001","unstructured":"Van Offel JF, Schuerwegh AJ, Bridts CH, Bracke PG, Stevens WJ, De Clerck LS (2001) Influence of cyclic intravenous pamidronate on proinflammatory monocytic cytokine profiles and bone density in rheumatoid arthritis treated with low dose prednisolone and methotrexate. Clin Exp Rheumatol 19:13\u201320","journal-title":"Clin Exp Rheumatol"},{"key":"1256_CR52","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2249.2006.03216.x","volume":"146","author":"LD Carbone","year":"2006","unstructured":"Carbone LD, Warrington KJ, Barrow KD, Pugazhenthi M, Watsky MA, Somes G et al (2006) Pamidronate infusion in patients with systemic sclerosis results in changes in blood mononuclear cell cytokine profiles. Clin Exp Immunol 146:371\u2013380","journal-title":"Clin Exp Immunol"},{"key":"1256_CR53","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJM199903043400914","volume":"340","author":"V Kunzmann","year":"1999","unstructured":"Kunzmann V, Bauer E, Wilhelm M (1999) Gamma\/delta T-cell stimulation by pamidronate. N Engl J Med 340:737\u2013738","journal-title":"N Engl J Med"},{"key":"1256_CR54","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood.V96.2.384","volume":"96","author":"V Kunzmann","year":"2000","unstructured":"Kunzmann V, Bauer E, Feurle J, Weiissinger F, Tony HP, Wilhelm M (2000) Stimulation of gamma delta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 96:384\u2013392","journal-title":"Blood"},{"key":"1256_CR55","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4049\/jimmunol.174.1.252","volume":"174","author":"L Conti","year":"2005","unstructured":"Conti L, Casetti R, Cardone M, Varano B, Martino A, Belardelli F, Poccia F, Gessani S (2005) Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines. J Immunol 174:252\u2013260","journal-title":"J Immunol"},{"key":"1256_CR56","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S1701-2163(16)34026-9","volume":"30","author":"N Djokanovic","year":"2008","unstructured":"Djokanovic N, Klieger-Grossmann C, Koren G (2008) Does treatment with bisphosphonates endanger the human pregnancy? J Obstet Gynaecol Can 30:1146\u20131148","journal-title":"J Obstet Gynaecol Can"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-009-1256-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-009-1256-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-009-1256-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T13:54:18Z","timestamp":1590069258000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-009-1256-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,19]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["1256"],"URL":"https:\/\/doi.org\/10.1007\/s10067-009-1256-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,19]]}}}